Coloplast Statistics
Total Valuation
Coloplast has a market cap or net worth of 21.63 billion. The enterprise value is 25.31 billion.
| Market Cap | 21.63B |
| Enterprise Value | 25.31B |
Important Dates
The last earnings date was Tuesday, August 19, 2025.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | May 16, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 142.64M |
Valuation Ratios
The trailing PE ratio is 33.71 and the forward PE ratio is 23.84.
| PE Ratio | 33.71 |
| Forward PE | 23.84 |
| PS Ratio | 4.93 |
| PB Ratio | 8.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.95 |
| P/OCF Ratio | 21.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.34, with an EV/FCF ratio of 31.53.
| EV / Earnings | 39.45 |
| EV / Sales | 5.79 |
| EV / EBITDA | 18.34 |
| EV / EBIT | 21.31 |
| EV / FCF | 31.53 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.47.
| Current Ratio | 1.00 |
| Quick Ratio | 0.61 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | 2.75 |
| Debt / FCF | 4.75 |
| Interest Coverage | 9.54 |
Financial Efficiency
Return on equity (ROE) is 24.72% and return on invested capital (ROIC) is 11.59%.
| Return on Equity (ROE) | 24.72% |
| Return on Assets (ROA) | 9.82% |
| Return on Invested Capital (ROIC) | 11.59% |
| Return on Capital Employed (ROCE) | 20.30% |
| Revenue Per Employee | 260,922 |
| Profits Per Employee | 38,155 |
| Employee Count | 16,639 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.43 |
Taxes
In the past 12 months, Coloplast has paid 335.33 million in taxes.
| Income Tax | 335.33M |
| Effective Tax Rate | 34.33% |
Stock Price Statistics
The stock price has decreased by -28.65% in the last 52 weeks. The beta is 0.53, so Coloplast's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -28.65% |
| 50-Day Moving Average | 9.49 |
| 200-Day Moving Average | 10.52 |
| Relative Strength Index (RSI) | 53.14 |
| Average Volume (20 Days) | 224,435 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Coloplast had revenue of 4.39 billion and earned 641.53 million in profits. Earnings per share was 2.85.
| Revenue | 4.39B |
| Gross Profit | 2.96B |
| Operating Income | 1.19B |
| Pretax Income | 976.86M |
| Net Income | 641.53M |
| EBITDA | 1.34B |
| EBIT | 1.19B |
| Earnings Per Share (EPS) | 2.85 |
Balance Sheet
The company has 114.30 million in cash and 3.81 billion in debt, giving a net cash position of -3.70 billion.
| Cash & Cash Equivalents | 114.30M |
| Total Debt | 3.81B |
| Net Cash | -3.70B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.59B |
| Book Value Per Share | 11.50 |
| Working Capital | 472,295 |
Cash Flow
In the last 12 months, operating cash flow was 1.01 billion and capital expenditures -209.38 million, giving a free cash flow of 802.59 million.
| Operating Cash Flow | 1.01B |
| Capital Expenditures | -209.38M |
| Free Cash Flow | 802.59M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.55%, with operating and profit margins of 27.19% and 14.62%.
| Gross Margin | 67.55% |
| Operating Margin | 27.19% |
| Pretax Margin | 22.27% |
| Profit Margin | 14.62% |
| EBITDA Margin | 30.57% |
| EBIT Margin | 27.19% |
| FCF Margin | 18.29% |
Dividends & Yields
This stock pays an annual dividend of 0.19, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 0.19 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | -0.42% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 121.67% |
| Buyback Yield | -0.25% |
| Shareholder Yield | 1.77% |
| Earnings Yield | 2.97% |
| FCF Yield | 3.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Coloplast has an Altman Z-Score of 5.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.05 |
| Piotroski F-Score | 6 |